PBIGF closed Friday higher at $0.15, an increase of 4.9783% from Thursday's close, completing a monthly increase of 7.7778% or $0.01. Over the past 12 months, PBIGF stock lost -37.5804%.
PBIGF is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Paradigm Biopharmaceuticals Limited has completed 1 stock splits, with the recent split occurring on Nov 01, 2023.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on ASX (AUD).